ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

Sarah M. Belcher; Emily Mackler; Benyam Muluneh; Pamela K. Ginex; Mary K. Anderson; Elizabeth Bettencourt; Ryan K. Dasgupta; Jennifer Elliott; Erica Hall; Michelle Karlin; Diana Kostoff; Victoria K. Marshall; Vanessa E. Millisor; Maegan Molnar; Susan M. Schneider; Janelle Tipton; Susan Yackzan; Kristine B. Lefebvre; Kapeena Sivakumaran; Haya Waseem; Rebecca L. Morgan

doi:10.1188/22.ONF.279-295

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

Sarah M. Belcher
, Emily Mackler
, Benyam Muluneh
, Pamela K. Ginex
, Mary K. Anderson
, Elizabeth Bettencourt
, Ryan K. Dasgupta
, Jennifer Elliott
, Erica Hall
, Michelle Karlin
, Diana Kostoff
, Victoria K. Marshall
, Vanessa E. Millisor
, Maegan Molnar
, Susan M. Schneider
, Janelle Tipton
, Susan Yackzan
, Kristine B. Lefebvre
, Kapeena Sivakumaran
, Haya Waseem

Rebecca L. Morgan

Office of the Dean of Nursing

University of Pittsburgh
Pharmacists Optimizing Oncology Care Excellence in Michigan
University of North Carolina at Chapel Hill
Kosair Children's Hospital
Palo Alto Medical Foundation
Henry Ford Health System
National Coalition for Cancer Survivorship
P.A.
Texas Oncology
University of South Florida
Henry Ford Cancer Institute
Waco Therapy and Holistic Wellness Services
National Coalition for Cancer Survivorship
Duke University
Purdue University
Cancer Service Line at Baptist Health System
Oncology Nursing Society
Evidence Foundation
McMaster University

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Abstract

PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral anticancer medications (OAMs). METHODOLOGIC APPROACH: A panel of healthcare professionals and patient representatives developed a clinical practice guideline to support patients taking OAMs. GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology and criteria for trustworthy guidelines were followed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. A quantitative or narrative synthesis of the evidence was completed. Certainty of the evidence was assessed using GRADE.

Original language	English
Pages (from-to)	279-295
Number of pages	17
Journal	Oncology nursing forum
Volume	49
Issue number	4
DOIs	https://doi.org/10.1188/22.ONF.279-295
State	Published - Jul 2022

Keywords

medication adherence
nursing
oncology care
oral anticancer medication
scoping review

Access to Document

10.1188/22.ONF.279-295

Cite this

Belcher, S. M., Mackler, E., Muluneh, B., Ginex, P. K., Anderson, M. K., Bettencourt, E., Dasgupta, R. K., Elliott, J., Hall, E., Karlin, M., Kostoff, D., Marshall, V. K., Millisor, V. E., Molnar, M., Schneider, S. M., Tipton, J., Yackzan, S., Lefebvre, K. B., Sivakumaran, K., ... Morgan, R. L. (2022). ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications. Oncology nursing forum, 49(4), 279-295. https://doi.org/10.1188/22.ONF.279-295

@article{c86d5d1d01884c888335fd0a1e4b2352,

title = "ONS Guidelines{\texttrademark} to Support Patient Adherence to Oral Anticancer Medications",

abstract = "PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral anticancer medications (OAMs). METHODOLOGIC APPROACH: A panel of healthcare professionals and patient representatives developed a clinical practice guideline to support patients taking OAMs. GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology and criteria for trustworthy guidelines were followed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. A quantitative or narrative synthesis of the evidence was completed. Certainty of the evidence was assessed using GRADE.",

keywords = "medication adherence, nursing, oncology care, oral anticancer medication, scoping review",

author = "Belcher, \{Sarah M.\} and Emily Mackler and Benyam Muluneh and Ginex, \{Pamela K.\} and Anderson, \{Mary K.\} and Elizabeth Bettencourt and Dasgupta, \{Ryan K.\} and Jennifer Elliott and Erica Hall and Michelle Karlin and Diana Kostoff and Marshall, \{Victoria K.\} and Millisor, \{Vanessa E.\} and Maegan Molnar and Schneider, \{Susan M.\} and Janelle Tipton and Susan Yackzan and Lefebvre, \{Kristine B.\} and Kapeena Sivakumaran and Haya Waseem and Morgan, \{Rebecca L.\}",

year = "2022",

month = jul,

doi = "10.1188/22.ONF.279-295",

language = "English",

volume = "49",

pages = "279--295",

journal = "Oncology nursing forum",

issn = "0190-535X",

number = "4",

}

Belcher, SM, Mackler, E, Muluneh, B, Ginex, PK, Anderson, MK, Bettencourt, E, Dasgupta, RK, Elliott, J, Hall, E, Karlin, M, Kostoff, D, Marshall, VK, Millisor, VE, Molnar, M, Schneider, SM, Tipton, J, Yackzan, S, Lefebvre, KB, Sivakumaran, K, Waseem, H & Morgan, RL 2022, 'ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications', Oncology nursing forum, vol. 49, no. 4, pp. 279-295. https://doi.org/10.1188/22.ONF.279-295

TY - JOUR

T1 - ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

AU - Belcher, Sarah M.

AU - Mackler, Emily

AU - Muluneh, Benyam

AU - Ginex, Pamela K.

AU - Anderson, Mary K.

AU - Bettencourt, Elizabeth

AU - Dasgupta, Ryan K.

AU - Elliott, Jennifer

AU - Hall, Erica

AU - Karlin, Michelle

AU - Kostoff, Diana

AU - Marshall, Victoria K.

AU - Millisor, Vanessa E.

AU - Molnar, Maegan

AU - Schneider, Susan M.

AU - Tipton, Janelle

AU - Yackzan, Susan

AU - Lefebvre, Kristine B.

AU - Sivakumaran, Kapeena

AU - Waseem, Haya

AU - Morgan, Rebecca L.

PY - 2022/7

Y1 - 2022/7

N2 - PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral anticancer medications (OAMs). METHODOLOGIC APPROACH: A panel of healthcare professionals and patient representatives developed a clinical practice guideline to support patients taking OAMs. GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology and criteria for trustworthy guidelines were followed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. A quantitative or narrative synthesis of the evidence was completed. Certainty of the evidence was assessed using GRADE.

AB - PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral anticancer medications (OAMs). METHODOLOGIC APPROACH: A panel of healthcare professionals and patient representatives developed a clinical practice guideline to support patients taking OAMs. GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology and criteria for trustworthy guidelines were followed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. A quantitative or narrative synthesis of the evidence was completed. Certainty of the evidence was assessed using GRADE.

KW - medication adherence

KW - nursing

KW - oncology care

KW - oral anticancer medication

KW - scoping review

UR - https://www.scopus.com/pages/publications/85133293625

U2 - 10.1188/22.ONF.279-295

DO - 10.1188/22.ONF.279-295

M3 - Article

C2 - 35788731

AN - SCOPUS:85133293625

SN - 0190-535X

VL - 49

SP - 279

EP - 295

JO - Oncology nursing forum

JF - Oncology nursing forum

IS - 4

ER -

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this